ArticleBMJ open2018

Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.

Matthias Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.